202 related articles for article (PubMed ID: 32103551)
21. [Validity and controversies in the new postoperative pathologic TNM classification based on the results of surgical treatment of non-small cell lung cancer].
Hosokawa Y; Matsuge S; Murakami Y; Satoh K; Yamazaki S; Kan T; Hatakeyama H
Kyobu Geka; 2000 Oct; 53(11):910-4. PubMed ID: 11048440
[TBL] [Abstract][Full Text] [Related]
22. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.
Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH
Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175
[TBL] [Abstract][Full Text] [Related]
23. The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations.
Lin JH; Lin D; Xu L; Wang Q; Hu HH; Xu HP; He ZY
Oncotarget; 2017 Jan; 8(2):3412-3421. PubMed ID: 27926500
[TBL] [Abstract][Full Text] [Related]
24. A Population-based Study of Treatment Patterns and Survival of Patients With De Novo Stage IV Non-Small Cell Lung Cancer.
Batra A; Yusuf D; Hurry M; Walton RN; Devost N; Farrer C; Cheung WY
Am J Clin Oncol; 2021 Oct; 44(10):512-518. PubMed ID: 34380947
[TBL] [Abstract][Full Text] [Related]
25. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
[TBL] [Abstract][Full Text] [Related]
26. Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.
Kuiper JL; Hendriks LE; van der Wekken AJ; de Langen AJ; Bahce I; Thunnissen E; Heideman DA; Berk Y; Buijs EJ; Speel EJ; Krouwels FH; Smit HJ; Groen HJ; Dingemans AM; Smit EF
Lung Cancer; 2015 Sep; 89(3):255-61. PubMed ID: 26117231
[TBL] [Abstract][Full Text] [Related]
27. Surgery for small cell lung cancer: a retrospective analysis of 243 patients from Japanese Lung Cancer Registry in 2004.
Takei H; Kondo H; Miyaoka E; Asamura H; Yoshino I; Date H; Okumura M; Tada H; Fujii Y; Nakanishi Y; Eguchi K; Dosaka-Akita H; Kobayashi H; Sawabata N; Yokoi K;
J Thorac Oncol; 2014 Aug; 9(8):1140-5. PubMed ID: 25157766
[TBL] [Abstract][Full Text] [Related]
28. Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs.
Gui Q; Liu J; Li D; Xu C
World J Surg Oncol; 2017 Oct; 15(1):184. PubMed ID: 29037198
[TBL] [Abstract][Full Text] [Related]
29. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in lung cancer in a defined geographical area over two decades with a special emphasis on gender.
Svensson G; Ewers SB; Ohlsson O; Olsson H
Clin Respir J; 2013 Jan; 7(1):91-100. PubMed ID: 22380488
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of clinical variables on surgically resected small-cell lung cancer: Results of a retrospective multicenter analysis (FIGHT002A and HOT1301A).
Yokouchi H; Ishida T; Yamazaki S; Kikuchi H; Oizumi S; Uramoto H; Tanaka F; Harada M; Akie K; Sugaya F; Fujita Y; Fukuhara T; Takamura K; Kojima T; Harada T; Higuchi M; Matsuura Y; Honjo O; Minami Y; Watanabe N; Nishihara H; Suzuki H; Dosaka-Akita H; Isobe H; Nishimura M; Munakata M
Lung Cancer; 2015 Dec; 90(3):548-53. PubMed ID: 26604032
[TBL] [Abstract][Full Text] [Related]
32. Non-small Cell Lung Cancer as a Chronic Disease - A Prospective Study from the Czech TULUNG Registry.
Bratova M; Karlinova B; Skrickova J; Pesek M; Kolek V; Koubkova L; Hrnciarik M; Krejci J; Barinova M; Havel L; Grygarkova I; Brat K
In Vivo; 2020; 34(1):369-379. PubMed ID: 31882501
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
[TBL] [Abstract][Full Text] [Related]
34. SUVmax during 18FDG-PET scanning in small cell lung cancer: similar information as in non-small cell lung cancer?
van der Leest C; Smit EF; Baas J; Versteijlen RJ; van Walree N; Hoogsteden HC; Aerts JG
Lung Cancer; 2012 Apr; 76(1):67-71. PubMed ID: 21996089
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological features, risk and survival in lung cancer survivors with therapy-related acute myeloid leukaemia.
Wang H; Yin Y; Wang R; Huang J; Xue H; Cheng Y; Zhang L; Chen C
BMC Cancer; 2020 Nov; 20(1):1081. PubMed ID: 33172389
[TBL] [Abstract][Full Text] [Related]
36. Lung Cancer Survival Trends in the Veterans Health Administration.
Moghanaki D; Taylor J; Bryant AK; Vitzthum LK; Sebastian N; Gutman D; Burns A; Huang Z; Lewis JA; Spalluto LB; Williams CD; Sullivan DR; Slatore CG; Behera M; Stokes WA
Clin Lung Cancer; 2024 May; 25(3):225-232. PubMed ID: 38553325
[TBL] [Abstract][Full Text] [Related]
37. Small-cell lung cancer: prognostic factors and changing treatment over 15 years.
Gaspar LE; McNamara EJ; Gay EG; Putnam JB; Crawford J; Herbst RS; Bonner JA
Clin Lung Cancer; 2012 Mar; 13(2):115-22. PubMed ID: 22000695
[TBL] [Abstract][Full Text] [Related]
38. Real world utilization of EGFR TKIs and prognostic factors for survival in NSCLC during 2010-2016 in Sweden: A nationwide observational study.
Bergqvist M; Christensen HN; Wiklund F; Bergström S
Int J Cancer; 2020 May; 146(9):2510-2517. PubMed ID: 31350754
[TBL] [Abstract][Full Text] [Related]
39. Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC).
Labbé C; Cabanero M; Korpanty GJ; Tomasini P; Doherty MK; Mascaux C; Jao K; Pitcher B; Wang R; Pintilie M; Leighl NB; Feld R; Liu G; Bradbury PA; Kamel-Reid S; Tsao MS; Shepherd FA
Lung Cancer; 2017 Sep; 111():23-29. PubMed ID: 28838393
[TBL] [Abstract][Full Text] [Related]
40. Comparison of survival rate in primary non-small-cell lung cancer among elderly patients treated with radiofrequency ablation, surgery, or chemotherapy.
Lee H; Jin GY; Han YM; Chung GH; Lee YC; Kwon KS; Lynch D
Cardiovasc Intervent Radiol; 2012 Apr; 35(2):343-50. PubMed ID: 21626257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
